Skip to content
★ Sign in to follow
BB
Total declarations
39
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€22.6M

Latest filing published 19 Dec 2017 for Dolby Laboratories, Inc., €263k.

Filing timeline

BuySale
Bob Borchers

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

Bob Borchers: trading record in brief

Bob Borchers appears in our data through filings on Dolby Laboratories, Inc. shares, published by SEC (Form 4). We count 39 filings; the first trade dates from 15 January 2014 and the latest from 15 December 2017.

No open-market purchase appears, only 15 sales worth €22.6M. Besides market trades, the filings include 10 share grants and 13 option exercises. 2017 to date brings no purchases and 14 sales.

On 19 December 2017 came the latest disclosure, a share grant for €263k in Dolby Laboratories, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Bob Borchers

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations31 total
  • ◆
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    309,158 USD11SEC
    5,069 shares@ US$60.991.0% of flowClass A Common StockSEC:0001209191-17-066566:0
  • ◇
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    2M USD12SEC
    50,000 shares@ US$41.316.3% of flowClass A Common StockSEC:0001209191-17-063134:0
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    3M USD30SEC
    50,000 shares@ US$62.729.6% of flowClass A Common StockSEC:0001209191-17-063134:1
  • ◇
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    1M USD11SEC
    36,276 shares@ US$41.314.6% of flowClass A Common StockSEC:0001209191-17-063134:2
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    2M USD30SEC
    36,276 shares@ US$61.816.9% of flowClass A Common StockSEC:0001209191-17-063134:3
  • ◇
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    589,858 USD11SEC
    13,724 shares@ US$42.981.8% of flowClass A Common StockSEC:0001209191-17-063134:4
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    848,280 USD29SEC
    13,724 shares@ US$61.812.6% of flowClass A Common StockSEC:0001209191-17-063134:5
  • ◇
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    2M USD12SEC
    48,361 shares@ US$42.986.4% of flowClass A Common StockSEC:0001209191-17-063134:6
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    3M USD30SEC
    48,361 shares@ US$61.939.2% of flowClass A Common StockSEC:0001209191-17-063134:7
  • ◇
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    1M USD11SEC
    33,179 shares@ US$41.314.3% of flowClass A Common StockSEC:0001288257-17-000015:0
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    2M USD30SEC
    33,179 shares@ US$61.746.4% of flowClass A Common StockSEC:0001288257-17-000015:1
  • ◇
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    873,635 USD11SEC
    26,354 shares@ US$33.152.7% of flowClass A Common StockSEC:0001209191-17-061666:0
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    2M USD29SEC
    26,354 shares@ US$61.005.0% of flowClass A Common StockSEC:0001209191-17-061666:1
  • ◇
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    976,816 USD11SEC
    23,646 shares@ US$41.313.0% of flowClass A Common StockSEC:0001209191-17-061666:2
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    1M USD29SEC
    23,646 shares@ US$61.004.5% of flowClass A Common StockSEC:0001209191-17-061666:3
  • ◇
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    694,876 USD11SEC
    16,821 shares@ US$41.312.1% of flowClass A Common StockSEC:0001209191-17-061666:4
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    1M USD29SEC
    16,821 shares@ US$61.093.2% of flowClass A Common StockSEC:0001209191-17-061666:5
  • ◇
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    2M USD12SEC
    50,000 shares@ US$41.316.4% of flowClass A Common StockSEC:0001209191-17-061666:6
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    3M USD30SEC
    50,000 shares@ US$61.329.5% of flowClass A Common StockSEC:0001209191-17-061666:7
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    599,399 USD26SEC
    11,666 shares@ US$51.382.0% of flowClass A Common StockSEC:0001209191-17-032809:0
  • ●
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    0SEC
    1,555 shares0Class A Common StockSEC:0001209191-17-032809:1
  • ◆
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    228,354 USD11SEC
    4,666 shares@ US$48.940.8% of flowClass A Common StockSEC:0001209191-17-004578:0
  • ◆
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    0SEC
    11,500 shares0Class A Common StockSEC:0001209191-16-156009:0
  • ◆
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    116,890 USD11SEC
    2,569 shares@ US$45.500.4% of flowClass A Common StockSEC:0001209191-16-156009:1
  • ▼
    SVP & Chief Marketing OfficerExecutivesDolby Laboratories, Inc.
    432,277 USD29SEC
    8,649 shares@ US$49.981.4% of flowClass A Common StockSEC:0001209191-16-134998:0

25 of 31 declarations